SETDB1 targeting SESN2 regulates mitochondrial damage and oxidative stress in renal ischemia-reperfusion injury
- BMC Biol. 2024 Oct 23;22(1):246. doi: 10.1186/s12915-024-02048-z.
- 1. Department of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
- 2. Department of Organ Transplantation, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
- 3. Wuhan University Institute of Urological Disease, Wuhan, Hubei, China.
- 4. Department of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China. [email protected].
- 5. Wuhan University Institute of Urological Disease, Wuhan, Hubei, China. [email protected].
- 6. Department of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China. [email protected].
- 7. Wuhan University Institute of Urological Disease, Wuhan, Hubei, China. [email protected].
- 8. Department of Urology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China. [email protected].
- 9. Wuhan University Institute of Urological Disease, Wuhan, Hubei, China. [email protected].
- # Contributed equally.
Background: The role of Histone Methyltransferase SETDB1 in renal ischemia-reperfusion (I/R) injury has not been explored yet. This study aims to investigate the potential mechanism of SETDB1 in regulating renal I/R injury and its impact on mitochondrial damage and oxidative stress.
Methods: The in vivo model of renal I/R in mice and the in vitro model of hypoxia/reoxygenation (H/R) in human renal tubular epithelial cells (HK-2) were constructed to detect the expression of SETDB1. Next, the specific inhibitor (R,R)-59 and knockdown viruses were used to inhibit SETDB1 and verify its effects on mitochondrial damage and oxidative stress. Chromatin immunoprecipitation (ChIP) and coimmunoprecipitation (CoIP) were implemented to explore the in-depth mechanism of SETDB1 regulating renal I/R injury.
Results: The study found that SETDB1 had a regulatory role in mitochondrial damage and oxidative stress during renal I/R injury. Notably, SESN2 was identified as a target of SETDB1, and its expression was under the influence of SETDB1. Besides, SESN2 mediated the regulation of SETDB1 on renal I/R injury. Through deeper mechanistic studies, we uncovered that SETDB1 collaborates with heterochromatin HP1β, facilitating the labeling of H3K9me3 on the SESN2 promoter and impeding SESN2 expression.
Conclusions: The SETDB1/HP1β-SESN2 axis emerges as a potential therapeutic strategy for mitigating renal I/R injury.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Cancer